About

China Pharma Desk publishes same-day English notes on China’s pharmaceutical and biotech industry for people who work in or follow the sector worldwide.

Most days you will find Desk briefs—short notes on what moved. Some days a Desk analysis when a regulation or a deal needs more room: what happened, how to read it, and why it matters.

Readers include industry teams, investors, advisors, and others who need China-field context with sources they can check. We do not write for doctors or patients as clinical end users.

This site is the public archive. Subscribe to the email edition when it launches, or write us if a conversation would help.

Industry information only—not medical advice or investment advice.

Contact: [email protected]